AG-221, a First-in-Class Therapy Targeting Acute Myeloid Leukemia Harboring Oncogenic <i>IDH2</i> MutationsKatharine Yen, Shinsan M. Su, Jeremy Travins et al.|Cancer Discovery|2017Cited by 457
The mechanosensitive Piezo1 channel mediates heart mechano-chemo transductionFan Jiang, Bailong Xiao|Nature Communications|2021Cited by 292
Antibody-Mediated Delivery of Chimeric BRD4 Degraders. Part 2: Improvement of In Vitro Antiproliferation Activity and In Vivo Antitumor EfficacyPeter S. Dragovich, Xiaoyu Zhu, Thomas H. Pillow et al.|Journal of Medicinal Chemistry|2021Cited by 168
Community-Wide Assessment of Protein-Interface Modeling Suggests Improvements to Design MethodologySarel J. Fleishman, Ying Chen, Mayuko Takeda‐Shitaka et al.|Journal of Molecular Biology|2011Cited by 136